Both revenue and EBITDA showed strong double-digit growth, with margins expanding as well. Shares of Mankind Pharma Ltd ended at ₹2,552.90, down by ₹22.10 or 0.86%, on the BSE.
Both revenue and EBITDA showed strong double-digit growth, with margins expanding as well. Shares of Mankind Pharma Ltd ended at ₹2,552.90, down by ₹22.10 or 0.86%, on the BSE.